reports
- ABGSC Seafood Research
- Martin Kaland
- Simon Brun
- ABGSC Seafood Research
- Martin Kaland
- Simon Brun
Elliptic Labs Launching on Transsion’s Infinix GT 20 Pro Smartphone
OSLO, Norway--(BUSINESS WIRE)-- (OSE:), a global AI software company and the world leader in AI Virtual Smart Sensors™ currently deployed in over 500 million devices, has launched its AI Virtual Proximity Sensor™ INNER BEAUTY® on Transsion’s Infinix GT 20 Pro smartphone. Transsion, the fourth largest smartphone maker globally, is releasing the Infinix GT 20 Pro smartphone for the global market. The Infinix GT 20 Pro is driven by Elliptic Labs’ . . “Elliptic Labs has worked with Transsion since 2022, contributing to its ascent as the fourth largest smartphone manufacturer worldwide,” said L...
IBA signs contract with Yale New Haven Health and Hartford HealthCare ...
IBA signs contract with Yale New Haven Health and Hartford HealthCare to install Proteus®ONE proton therapy solution in Connecticut, US Louvain-La-Neuve, Belgium, 2 May 2024 - IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, today announces that it has signed a contract with the Connecticut Proton Therapy Center, a collaboration between Yale New Haven Health, Hartford HealthCare and Proton International, for the installation of a Proteus®ONE1 compact proton therapy system. The contract includes a multi-year operation and maintenance agreement,...
WORLDLINE : Q1 2024 revenue
WORLDLINE : Q1 2024 revenue Q1 2024 revenueQ1 2024 Group revenue: € 1,097 million +2.5% organically +3.9% in Merchant Services Transformation initiatives on trackRedesign of Merchant Services operating model with two new go-to-market channelsPower24 transformation plan in motion and rolled-out in targeted countries Launch of Crédit Agricole and Worldline joint-venture Unconditional approval received from the European Commission in MarchJV to operate under new brand CAWL, providing innovative payment services to all merchants in France Governance updateWilfried Verstraete coopted as futu...
IBA signe un contrat avec Yale New Haven Health et Hartford HealthCare...
IBA signe un contrat avec Yale New Haven Health et Hartford HealthCare pour l’installation d’une solution de protonthérapie Proteus®ONE dans le Connecticut, aux États-Unis Louvain-la-Neuve, Belgique, le 2 mai 2024 - IBA (Ion Beam Applications S.A., EURONEXT), le leader mondial de la technologie d’accélération de particules, annonce aujourd'hui avoir signé un contrat avec le Connecticut Proton Therapy Center, une collaboration entre Yale New Haven Health, Hartford HealthCare et Proton International, pour l'installation d'un système compact de protonthérapie Proteus®ONE1. Le contrat comprend ...
Press Release: Beyfortus real-world evidence published in The Lancet s...
Press Release: Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant RSV hospitalizations Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant RSV hospitalizations New real-world evidence shows Beyfortus (nirsevimab) substantially reduced RSV lower respiratory tract disease and hospitalizations in infants during the 2023-2024 RSV season, versus no intervention1-6Results add to the consistent high efficacy of Beyfortus against medically attended RSV lower respiratory tract disease, shown in the pivotal clinical studies and the o...
Communiqué de presse : Des données de vie réelle concernant Beyfortus ...
Communiqué de presse : Des données de vie réelle concernant Beyfortus publiées dans The Lancet montrent une réduction de 82 % des hospitalisations de nourrissons dues au VRS Des données de vie réelle concernant Beyfortus publiées dans The Lancet montrent une réduction de 82 % des hospitalisations de nourrissons dues au VRS De nouvelles données de vie réelle montrent que Beyfortus (nirsevimab) a permis de réduire sensiblement les infections des voies respiratoires inférieures dues au VRS chez les nourrissons, de même que les hospitalisations, au cours de la saison virale 2023-2024, compa...
ArcelorMittal S.A.: ArcelorMittal reports first quarter 2024 results
ArcelorMittal S.A.: ArcelorMittal reports first quarter 2024 results Luxembourg, May 2, 2024 - ArcelorMittal (referred to as “ArcelorMittal” or the “Company” or the "Group") (MT (New York, Amsterdam, Paris, Luxembourg), MTS (Madrid)), the world’s leading integrated steel and mining company, today announced results1 for the three-month period ended March 31, 2024. 1Q 2024 key highlights: Health and safety focus: Protecting employee health and wellbeing remains the overarching priority of the Company; the Company-wide audit of safety by dss+ is progressing and will support our p...
Voting Rights and Denominator
Voting Rights and Denominator Press ReleaseRegulated InformationAntwerp, 2 May 2024– 7.00 a.m. CET In application of Article 15 of the Law of May 2, 2007 on the disclosure of major shareholdings in issuers whose shares are admitted for trading on a regulated market, VGP publishes, by means of a press release and on its website, the total share capital, the total number of securities with voting rights and the total number of voting rights at the latest at the end of each month in which any of these numbers has changed. Situation as at 30 April 2024: Total share capital:€ 136,091,705.08...
Stemrechten en Noemer
Stemrechten en Noemer PersberichtGereglementeerde informatieAntwerpen, 2 Mei 2025, 07:00 CET In toepassing van artikel 15 van de wet van 2 mei 2007 op de openbaarmaking van belangrijke deelnemingen in emittenten waarvan aandelen zijn toegelaten tot de verhandeling op een gereglementeerde markt, publiceert VGP door middel van een persbericht en op haar website het totaal kapitaal, het totaal aantal stemrechtverlenende effecten en het totale aantal stemrechten uiterlijk op het einde van elke maand waarin één van deze aantallen is gewijzigd. Situatie op 30 April 2024: Totaal kapitaal:€ 13...
Increase of Share Capital in Connection with Realisation of the Staff ...
Increase of Share Capital in Connection with Realisation of the Staff Options Programme and Subscription Results The Supervisory Board of AS LHV Group decided to increase the share capital of the Company by EUR 435,619. The increase of the share capital was triggered by the need to issue new shares to staff members participating in the share options programme approved with the resolution of the general meeting on 13 March 2020. A total of 138 current and former employees of LHV participated in the issue of AS LHV Group shares, subscribing a total of 4,356,190 shares for a total of EUR 4,020...
argenx to Report First Quarter 2024 Financial Results and Business Upd...
argenx to Report First Quarter 2024 Financial Results and Business Update on May 9, 2024 May 2, 2024Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that it will host a conference call and audio webcast on Thursday, May 9, 2024 at 2:30 PM CET (8:30 AM ET) to discuss its first quarter 2024 financial results and provide a business update. A webcast of the live call may be accessed on the Investors section of the argenx website at . A replay of the ...
ForFarmers trading update Q1 2024: Like-for-like volume growth and str...
ForFarmers trading update Q1 2024: Like-for-like volume growth and strong increase operational profitability Lochem, 2 May 2024 ForFarmers trading update Q1 2024Like-for-like volume growth and strong increase operational profitability Pieter Wolleswinkel, CEO ForFarmers: “Our (compound) feed volumes show an increase. This is a great achievement and shows that we have been able to further strengthen our market position with our focused local market approach. The volume development confirms that we are contributing to a good return on the farm/a profitable farming business. Our e...
ONWARD® Medical Convocation of the 2024 Annual General Meeting of Shar...
ONWARD® Medical Convocation of the 2024 Annual General Meeting of Shareholders and Proposed Resolutions EINDHOVEN, the Netherlands, May 02, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), a medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (SCI), today has convened the 2024 Annual General Meeting of Shareholders (AGM), which will include consideration of the resolutions to be submitted for adoption at the AGM, which will be held in Amsterdam, the Netherlands, on ...
ForFarmers operationele voortgangsrapportage Q1 2024: Autonome volumeg...
ForFarmers operationele voortgangsrapportage Q1 2024: Autonome volumegroei en sterke stijging operationele winstgevendheid Lochem, 2 mei 2024 ForFarmers operationele voortgangsrapportage Q1 2024Autonome volumegroei en sterke stijging operationele winstgevendheid Pieter Wolleswinkel, CEO ForFarmers: “Onze (meng)voervolumes laten een stijging zien. Dat is een mooie prestatie en laat zien dat wij, met onze gerichte lokale aanpak, onze marktpositie verder hebben weten te versterken. De volumeontwikkeling bevestigt dat we bijdragen aan een goed rendement op het boerenbedrijf. Onze ef...
Interim Report Q1 2024: GN Store Nord delivered organic revenue growth...
Interim Report Q1 2024: GN Store Nord delivered organic revenue growth of 5% reaching an EBITA margin of 12.5% Highlights GN delivered continued execution across the three divisions resulting in 5% organic revenue growth for the GroupThe Hearing division delivered continued market share gains leading to 14% organic revenue growth, resulting in 8.2 percentage point increase in the divisional profit margin supported by synergies and a successful ReSound Nexia roll-outThe Enterprise division continued its relentless commercial execution in a stabilizing market leading to 0% organic revenue gr...
ING posts 1Q2024 net result of €1,578 million, with strong commercial ...
ING posts 1Q2024 net result of €1,578 million, with strong commercial performance ING posts 1Q2024 net result of €1,578 million,with strong commercial performance 1Q2024 profit before tax of €2,293 million; 4-quarter rolling return on equity of 14.8% on higher CET1 ratio of 14.8% • Net interest income from lending and liabilities remains strong • Double-digit growth in fee income, with strong contributions from both Retail and Wholesale Banking • Increase of 99,000 primary customers, net core deposits growth of €13.5 billion and net core lending growth of €4.2 billion while k...
- ABGSC Seafood Research
- Martin Kaland
- Simon Brun
- ABGSC Seafood Research
- Martin Kaland
- Simon Brun
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.